Liquid Biopsy For Cancer Diagnostics Market, Global Outlook and Forecast 2023-2029
Report ID
41324
Publisher
Market Monitor Global
Published Date
08-Nov
Delivery Format
PDF
No of Report Page
102
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Liquid Biopsy For Cancer Diagnostics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Liquid Biopsy For Cancer Diagnostics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Liquid Biopsy For Cancer Diagnostics, challenges faced by the industry, and potential opportunities for market players.
The global Liquid Biopsy For Cancer Diagnostics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Liquid Biopsy For Cancer Diagnostics market presents opportunities for various stakeholders, including Hospital, Diagnostic Center. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Liquid Biopsy For Cancer Diagnostics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Liquid Biopsy For Cancer Diagnostics market was valued at US$ 3398.9 million in 2022 and is projected to reach US$ 7703.3 million by 2029, at a CAGR of 13.1% during the forecast period.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
Key Features:
The research report on the Liquid Biopsy For Cancer Diagnostics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Liquid Biopsy For Cancer Diagnostics market.
Market Overview: The report provides a comprehensive overview of the Liquid Biopsy For Cancer Diagnostics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Blood Test, Urine Test), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Liquid Biopsy For Cancer Diagnostics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Liquid Biopsy For Cancer Diagnostics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Liquid Biopsy For Cancer Diagnostics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Liquid Biopsy For Cancer Diagnostics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Liquid Biopsy For Cancer Diagnostics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Liquid Biopsy For Cancer Diagnostics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Liquid Biopsy For Cancer Diagnostics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Liquid Biopsy For Cancer Diagnostics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Liquid Biopsy For Cancer Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Blood Test
    Urine Test
    Saliva Test
Market segment by Application
    Hospital
    Diagnostic Center
    Others
Global Liquid Biopsy For Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    F. Hoffman La Roche Ltd.
    Thermo Fisher Scientific Inc.
    Agilent Technologies Inc.
    Illumina Inc.
    The Menarini Group
    Bio-Rad Laboratories Inc.
    QIAGEN Inc.
    Exact Sciences Corporation
    Bio-Techne Corporation
    ArcherDX Inc.
    Neogenomics Laboratories Inc.
    Guardant Health Inc.
    Myriad Genetics Inc.
    Foundation Medicine Inc.
    Amoy Diagnostics Co. Ltd.
    Biocartis Group NV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liquid Biopsy For Cancer Diagnostics, market overview.
Chapter 2: Global Liquid Biopsy For Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Liquid Biopsy For Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liquid Biopsy For Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Liquid Biopsy For Cancer Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Liquid Biopsy For Cancer Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Liquid Biopsy For Cancer Diagnostics Overall Market Size
    2.1 Global Liquid Biopsy For Cancer Diagnostics Market Size: 2022 VS 2029
    2.2 Global Liquid Biopsy For Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Liquid Biopsy For Cancer Diagnostics Players in Global Market
    3.2 Top Global Liquid Biopsy For Cancer Diagnostics Companies Ranked by Revenue
    3.3 Global Liquid Biopsy For Cancer Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Liquid Biopsy For Cancer Diagnostics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Liquid Biopsy For Cancer Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Liquid Biopsy For Cancer Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Liquid Biopsy For Cancer Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Liquid Biopsy For Cancer Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Liquid Biopsy For Cancer Diagnostics Market Size Markets, 2022 & 2029
        4.1.2 Blood Test
        4.1.3 Urine Test
        4.1.4 Saliva Test
    4.2 By Type - Global Liquid Biopsy For Cancer Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2023
        4.2.2 By Type - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2024-2029
        4.2.3 By Type - Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Liquid Biopsy For Cancer Diagnostics Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Diagnostic Center
        5.1.4 Others
    5.2 By Application - Global Liquid Biopsy For Cancer Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2023
        5.2.2 By Application - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2024-2029
        5.2.3 By Application - Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Liquid Biopsy For Cancer Diagnostics Market Size, 2022 & 2029
    6.2 By Region - Global Liquid Biopsy For Cancer Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2023
        6.2.2 By Region - Global Liquid Biopsy For Cancer Diagnostics Revenue, 2024-2029
        6.2.3 By Region - Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2029
        6.3.2 US Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.3.3 Canada Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.3.4 Mexico Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2029
        6.4.2 Germany Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.3 France Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.4 U.K. Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.5 Italy Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.6 Russia Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.7 Nordic Countries Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.4.8 Benelux Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2029
        6.5.2 China Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.5.3 Japan Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.5.4 South Korea Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.5.5 Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.5.6 India Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2029
        6.6.2 Brazil Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.6.3 Argentina Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Liquid Biopsy For Cancer Diagnostics Revenue, 2018-2029
        6.7.2 Turkey Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.7.3 Israel Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.7.4 Saudi Arabia Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
        6.7.5 UAE Liquid Biopsy For Cancer Diagnostics Market Size, 2018-2029
7 Liquid Biopsy For Cancer Diagnostics Companies Profiles
    7.1 F. Hoffman La Roche Ltd.
        7.1.1 F. Hoffman La Roche Ltd. Company Summary
        7.1.2 F. Hoffman La Roche Ltd. Business Overview
        7.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.1.4 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.1.5 F. Hoffman La Roche Ltd. Key News & Latest Developments
    7.2 Thermo Fisher Scientific Inc.
        7.2.1 Thermo Fisher Scientific Inc. Company Summary
        7.2.2 Thermo Fisher Scientific Inc. Business Overview
        7.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.2.4 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.2.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
    7.3 Agilent Technologies Inc.
        7.3.1 Agilent Technologies Inc. Company Summary
        7.3.2 Agilent Technologies Inc. Business Overview
        7.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.3.5 Agilent Technologies Inc. Key News & Latest Developments
    7.4 Illumina Inc.
        7.4.1 Illumina Inc. Company Summary
        7.4.2 Illumina Inc. Business Overview
        7.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.4.4 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.4.5 Illumina Inc. Key News & Latest Developments
    7.5 The Menarini Group
        7.5.1 The Menarini Group Company Summary
        7.5.2 The Menarini Group Business Overview
        7.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.5.4 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.5.5 The Menarini Group Key News & Latest Developments
    7.6 Bio-Rad Laboratories Inc.
        7.6.1 Bio-Rad Laboratories Inc. Company Summary
        7.6.2 Bio-Rad Laboratories Inc. Business Overview
        7.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.6.4 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.6.5 Bio-Rad Laboratories Inc. Key News & Latest Developments
    7.7 QIAGEN Inc.
        7.7.1 QIAGEN Inc. Company Summary
        7.7.2 QIAGEN Inc. Business Overview
        7.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.7.4 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.7.5 QIAGEN Inc. Key News & Latest Developments
    7.8 Exact Sciences Corporation
        7.8.1 Exact Sciences Corporation Company Summary
        7.8.2 Exact Sciences Corporation Business Overview
        7.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.8.4 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.8.5 Exact Sciences Corporation Key News & Latest Developments
    7.9 Bio-Techne Corporation
        7.9.1 Bio-Techne Corporation Company Summary
        7.9.2 Bio-Techne Corporation Business Overview
        7.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.9.4 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.9.5 Bio-Techne Corporation Key News & Latest Developments
    7.10 ArcherDX Inc.
        7.10.1 ArcherDX Inc. Company Summary
        7.10.2 ArcherDX Inc. Business Overview
        7.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.10.4 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.10.5 ArcherDX Inc. Key News & Latest Developments
    7.11 Neogenomics Laboratories Inc.
        7.11.1 Neogenomics Laboratories Inc. Company Summary
        7.11.2 Neogenomics Laboratories Inc. Business Overview
        7.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.11.4 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.11.5 Neogenomics Laboratories Inc. Key News & Latest Developments
    7.12 Guardant Health Inc.
        7.12.1 Guardant Health Inc. Company Summary
        7.12.2 Guardant Health Inc. Business Overview
        7.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.12.4 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.12.5 Guardant Health Inc. Key News & Latest Developments
    7.13 Myriad Genetics Inc.
        7.13.1 Myriad Genetics Inc. Company Summary
        7.13.2 Myriad Genetics Inc. Business Overview
        7.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.13.4 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.13.5 Myriad Genetics Inc. Key News & Latest Developments
    7.14 Foundation Medicine Inc.
        7.14.1 Foundation Medicine Inc. Company Summary
        7.14.2 Foundation Medicine Inc. Business Overview
        7.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.14.4 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.14.5 Foundation Medicine Inc. Key News & Latest Developments
    7.15 Amoy Diagnostics Co. Ltd.
        7.15.1 Amoy Diagnostics Co. Ltd. Company Summary
        7.15.2 Amoy Diagnostics Co. Ltd. Business Overview
        7.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.15.4 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.15.5 Amoy Diagnostics Co. Ltd. Key News & Latest Developments
    7.16 Biocartis Group NV
        7.16.1 Biocartis Group NV Company Summary
        7.16.2 Biocartis Group NV Business Overview
        7.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Major Product Offerings
        7.16.4 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue in Global Market (2018-2023)
        7.16.5 Biocartis Group NV Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us